REGORAFENIB

Description

Overview

Regorafenib is a prescription oral medication classified as a multi-kinase inhibitor. It works by blocking multiple enzymes that promote cancer cell growth and tumor angiogenesis, making it an effective targeted therapy for certain advanced cancers. Regorafenib is commonly used in the treatment of metastatic colorectal cancer (mCRC), advanced gastrointestinal stromal tumors (GIST), and hepatocellular carcinoma (HCC), helping to slow disease progression and improve patient outcomes.

Key Features / Indications

• Active Ingredient: Regorafenib
• Therapeutic Class: Multi-Kinase Inhibitor / Targeted Therapy
• Indications:

o Metastatic colorectal cancer (mCRC) in patients previously treated with standard therapies

o Advanced gastrointestinal stromal tumors (GIST) after prior treatment

o Hepatocellular carcinoma (HCC) in patients with liver cancer

• Administration: Oral tablets, taken once daily as prescribed
• Mechanism of Action: Inhibits multiple kinases involved in tumor growth, angiogenesis, and metastasis
• Benefits:

o Targeted therapy for multiple advanced cancers

o Oral administration for patient convenience

o Slows tumor progression and improves survival in previously treated patients

Why Choose Oncomed Pharmacy?

Oncomed Pharmacy ensures access to authentic, high-quality Regorafenib with safe storage, handling, and delivery. Our expert pharmacists provide guidance on dosing, side-effect management, and supportive care to help patients receive their therapy safely and effectively. Choosing Oncomed Pharmacy guarantees reliable access to essential oncology medications with professional support throughout your treatment journey.

Uses of Medicine

Regorafenib is primarily used for:

• Treating metastatic colorectal cancer (mCRC)
• Managing advanced gastrointestinal stromal tumors (GIST)
• Treating hepatocellular carcinoma (HCC)
• Slowing tumor growth and disease progression in advanced cancers
• Supporting targeted therapy regimens in patients with prior treatments